logo
Plus   Neg
Share
Email

Dr. Reddy's Laboratories Launches Fosaprepitant For Injection In U.S. Market

Pharmaceutical company Dr. Reddy's Laboratories Ltd. (RDY) announced Wednesday the launch of Fosaprepitant for Injection, the therapeutic generic equivalent of EMEND (fosaprepitant) for injection, approved by the U.S. Food and Drug Administration (USFDA). It is among the first generics to launch this product.

The EMEND for Injection brand had an U.S. sales of approximately $279 million MAT for the most recent twelve months ending in July 2019 according to IQVIA Health.

Dr. Reddy's Fosaprepitant for Injection is available in 150 mg single-dose vial for reconstitution.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Dole Fresh Vegetables, Inc. has recalled a limited number of cases of organic romaine hearts, citing the potential for Pathogenic non-O157 E. coli, according to the U.S. Food and Drug Administration. The recall involves Dole Organic Romaine Hearts and Wild Harvest Organic Romaine Hearts. There is a possible health risk from E. coli in the two products. Guitar Center Inc., a retailer of musical instruments, lessons, repairs and rentals, has filed for Chapter 11 bankruptcy reorganization, aiming to significantly reduce its debt and continue its business amid ongoing struggles following the coronavirus pandemic. The company, which operates nearly 300 stores across the U.S., expects to complete the process before the end of this year. Amazon is offering new "Spoiler Free" ways to keep gifts a surprise, as well as to track, receive and pick up orders this holiday season. According to the company, the new features would help customers to face the challenge of keeping those special gifts under wraps as many families are opting to stay home amid the coronavirus pandemic.
Follow RTT